D'Avolio A - Search Results

1

Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease.

De Nicolò A, Cusato J, Bezzio C, Saibeni S, Vernero M, Disabato M, Caviglia GP, Ianniello A, Manca A, D'Avolio A, Ribaldone DG. De Nicolò A, et al. Nutrients. 2022 Dec 29;15(1):169. doi: 10.3390/nu15010169. Nutrients. 2022. PMID: 36615826 Free PMC article.

2

A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.

D'Avolio A, Simiele M, Siccardi M, Baietto L, Sciandra M, Oddone V, Stefani FR, Agati S, Cusato J, Bonora S, Di Perri G. D'Avolio A, et al. J Pharm Biomed Anal. 2011 Mar 25;54(4):779-88. doi: 10.1016/j.jpba.2010.10.011. Epub 2010 Nov 10. J Pharm Biomed Anal. 2011. PMID: 21071165

3

HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC).

D'Avolio A, Simiele M, De Francia S, Ariaudo A, Baietto L, Cusato J, Fava C, Saglio G, Di Carlo F, Di Perri G. D'Avolio A, et al. J Pharm Biomed Anal. 2012 Feb 5;59:109-16. doi: 10.1016/j.jpba.2011.10.003. Epub 2011 Oct 14. J Pharm Biomed Anal. 2012. PMID: 22036594 Free article.

4

Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment.

DʼAvolio A, Ciancio A, Siccardi M, Smedile A, Baietto L, Simiele M, Marucco DA, Cariti G, Calcagno A, de Requena DG, Sciandra M, Cusato J, Troshina G, Bonora S, Rizzetto M, Di Perri G. DʼAvolio A, et al. Ther Drug Monit. 2012 Apr;34(2):165-70. doi: 10.1097/FTD.0b013e31824bf778. Ther Drug Monit. 2012. PMID: 22406654 Free article.

5

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients.

D'Avolio A, De Nicolò A, Simiele M, Turini S, Agnesod D, Boglione L, Cusato J, Baietto L, Cariti G, Calcagno A, Sciandra M, Di Perri G, Bonora S. D'Avolio A, et al. J Pharm Biomed Anal. 2012 Jul;66:376-80. doi: 10.1016/j.jpba.2012.03.030. Epub 2012 Mar 28. J Pharm Biomed Anal. 2012. PMID: 22513116

6

Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS.

Baietto L, D'Avolio A, Marra C, Simiele M, Cusato J, Pace S, Ariaudo A, De Rosa FG, Di Perri G. Baietto L, et al. J Antimicrob Chemother. 2012 Nov;67(11):2645-9. doi: 10.1093/jac/dks285. Epub 2012 Aug 7. J Antimicrob Chemother. 2012. PMID: 22872447

7

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment.

D'Avolio A, Ciancio A, Siccardi M, Smedile A, Simiele M, Cusato J, Baietto L, Aguilar Marucco D, Cariti G, Calcagno A, Gonzalez de Requena D, Sciandra M, Troshina G, Caviglia GP, Bonora S, Rizzetto M, Di Perri G. D'Avolio A, et al. Ther Drug Monit. 2012 Dec;34(6):722-8. doi: 10.1097/FTD.0b013e318272e55a. Ther Drug Monit. 2012. PMID: 23149444 Free article.

8

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells.

D'Avolio A, Simiele M, Calcagno A, Siccardi M, Larovere G, Agati S, Baietto L, Cusato J, Tettoni M, Sciandra M, Trentini L, Di Perri G, Bonora S. D'Avolio A, et al. J Antimicrob Chemother. 2013 Apr;68(4):907-10. doi: 10.1093/jac/dks484. Epub 2012 Dec 5. J Antimicrob Chemother. 2013. PMID: 23221630 Free article.

9

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.

Boglione L, D'Avolio A, Cariti G, Gregori G, Burdino E, Baietto L, Cusato J, Ghisetti V, De Rosa FG, Di Perri G. Boglione L, et al. Liver Int. 2013 Apr;33(4):580-5. doi: 10.1111/liv.12091. Epub 2013 Jan 14. Liver Int. 2013. PMID: 23311449

10

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes.

Boglione L, D'Avolio A, Cariti G, Milia MG, Simiele M, De Nicolò A, Ghisetti V, Di Perri G. Boglione L, et al. J Viral Hepat. 2013 Apr;20(4):e11-9. doi: 10.1111/jvh.12018. Epub 2013 Feb 18. J Viral Hepat. 2013. PMID: 23490378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

331 results

Search Page